NIH-funded research R01 grant

Understanding iron deficiency in heart failure with preserved ejection fraction

Official title: Characterization of Functional Iron Deficiency and Repletion in Heart Failure with Preserved Ejection Fraction

Funded at Massachusetts General Hospital · NIH-10867349 · Data updated 2026-11-12

This study is looking at how low iron levels might affect people with heart failure who still have good heart function, focusing on how it impacts their ability to exercise and enjoy life, with the hope of finding better treatments to help them feel better.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMassachusetts General Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startAugust 15, 2021
Project endJune 30, 2025
Funding year2024
Award (this year)$601,100
NIH project number5R01HL159514-04
Project IDNIH-10867349 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults diagnosed with heart failure and preserved ejection fraction, particularly those experiencing symptoms related to iron deficiency.

Less likely to help

Patients with heart failure who do not have iron deficiency or those with reduced ejection fraction may not benefit from this research.

What this research studies

This research investigates the role of functional iron deficiency in patients with heart failure who have preserved ejection fraction (HFpEF). It aims to understand how low iron levels affect exercise capacity and overall quality of life in these patients. By examining the relationship between iron levels and heart function, the study seeks to identify potential treatments that could improve patient outcomes. The research will involve blood tests to measure iron levels and assess their impact on heart health.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for heart failure patients, enhancing their exercise capacity and quality of life.

How similar studies have gone: Previous research has shown that correcting iron deficiency in heart failure patients with reduced ejection fraction can improve outcomes, suggesting potential for similar benefits in those with preserved ejection fraction.

Where this research is happening

  • Massachusetts General Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Lewis, Gregory Dyer — Massachusetts General Hospital
  • Study coordinator: Lewis, Gregory Dyer

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.